GlaxoSmithKline PLC (GSK)

1,552.20
+17.60(+1.15%)
  • Volume:
    894,287
  • Bid/Ask:
    1,552.00/1,552.40
  • Day's Range:
    1,540.60 - 1,553.20

GSK Overview

Prev. Close
1,534.6
Day's Range
1,540.6-1,553.2
Revenue
33.33B
Open
1,542.4
52 wk Range
1,190.8-1,604.4
EPS
0.85
Volume
894,287
Market Cap
77.58B
Dividend (Yield)
80.00
(5.22%)
Average Volume (3m)
7,452,589
P/E Ratio
17.98
Beta
0.64
1-Year Change
10.72%
Shares Outstanding
5,007,979,212
Next Earnings Date
08 Feb 2022
What is your sentiment on GlaxoSmithKline PLC?
or
Vote to see community's results!

GlaxoSmithKline PLC Company Profile

Employees
94066

GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • Buy the stock investment GSK
    0
    • Buy the stock investment GSK
      0
      • Buy the stock investment GSK
        0
        • Buy the stock investment GSK
          0
          • Buy the stock investment GSK
            0
            • Buy the stock investment GSK
              0
              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.